Article metrics

Download PDFPDF

Phase 1/2 study of epacadostat in combination with ipilimumab in patients with unresectable or metastatic melanoma

 

Online download statistics by month:

Online download statistics by month: December 2019 to June 2025

AbstractFullPdf
Dec 2019220
Jan 202012121
Feb 202020203
Mar 202025253
Apr 202030303
May 202041418
Jun 2020525218
Jul 202027275
Aug 202025257
Sep 2020535310
Oct 2020444410
Nov 202021210
Dec 202029295
Jan 2021151515
Feb 2021363614
Mar 2021878721
Apr 2021868618
May 2021777711
Jun 202182827
Jul 202110010023
Aug 2021858521
Sep 2021888816
Oct 2021868620
Nov 2021939332
Dec 2021999918
Jan 20229610022
Feb 2022798014
Mar 2022444816
Apr 2022414316
May 2022252524
Jun 2022434517
Jul 2022798113
Aug 202210110112
Sep 2022929217
Oct 202210210314
Nov 2022929212
Dec 2022969614
Jan 202311011010
Feb 2023929315
Mar 2023979711
Apr 2023868617
May 2023929210
Jun 2023949417
Jul 2023828314
Aug 2023787810
Sep 2023818214
Oct 202387889
Nov 2023808215
Dec 20231081089
Jan 2024616212
Feb 2024686813
Mar 202410811024
Apr 2024747519
May 2024707015
Jun 2024383817
Jul 2024292915
Aug 2024252614
Sep 2024222213
Oct 2024282821
Nov 2024484918
Dec 2024484837
Jan 2025474729
Feb 2025363626
Mar 2025292920
Apr 2025363611
May 2025414220
Jun 2025242413
Total41244153968